Cerebral palsy (CP) is defined as a clinical syndrome characterized by a persistent disorder of posture or movement due to a non-progressive disorder of the immature brain. 1 The most common movement disorder in CP is a spastic paresis, 2 defined as a posture and movement-dependent tone regulation disorder. The clinical manifestations of spastic paresis vary widely, depending on the various impairments of muscle function that can be distinguished. Clinical symptoms of impaired muscle function can either be related to an impairment of muscle activation, leading to both deficit (or negative) and excess (or positive) symptoms, or to a change in biomechanical properties of muscles and connective tissues (Table I) . 3 The functional abilities of the child with spastic paresis often deteriorate during development. It is generally postulated that spasticity, a prominent symptom in spastic paresis, is related to this decline. Therefore, anti-spasticity treatment [5] [6] [7] plays an important role in treating the child with CP. However, many other symptoms, such as muscle paresis 8 (Table I) , also interfere, but remain unaffected by these anti-spasticity treatments. Careful assessment of which symptoms of impaired motor function are functionally limiting the individual patient is, therefore, essential in selecting the appropriate treatment. Clinical assessment to distinguish spasticity from other symptoms is only possible if a clear and unambiguous definition is given. Many different definitions have been proposed. [9] [10] [11] The most commonly used definition of spasticity is probably that of Lance: 'a motor disorder characterized by a velocitydependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex, as one component of the upper motor neuron syndrome'. 9 In this definition the clinical symptom of spasticity is a velocity-dependent increase in muscle tone. Stretching a muscle at a sufficiently high velocity is essential to elicit a stretch reflex at a certain angle in the range of motion, and the faster the stretch, the earlier and stronger the reflex component of the increased muscle tone will be. 12 Many studies have shown this stretch-related muscle activity, validating the velocity-dependency. [13] [14] [15] To assess spasticity clinically (without the use of special devices) and to verify the velocity-dependency, the intensity of the muscle tone elicited at very slow and at rapid passive joint movement is compared and graded. However, spasticity can also be quantified by measuring the joint angle at which the increase in muscle tone is encountered in a fast stretch 10, 13 and comparing it with the joint angle in a slow passive range of motion (ROM). As the severity of spasticity increases, this increase in muscle tone reflex is elicited earlier in the ROM. 16 It can lead to a 'catch' 12, 17 of the muscle, defined as the sudden appearance of increased muscle tone, which leads to an abrupt stop during the dynamic phase of movement in a joint, somewhere before the end of the ROM.
Of significant influence on the increase in muscle tone and the joint angle of appearance, although ignored in Lance's definition, 9 are the testing posture and the initial length from which the muscle is stretched, 15, [18] [19] [20] as well as any sensory stimulation (e.g. laughing) during the assessment. 21, 22 Various clinical instruments are used to evaluate spasticity. However, it is not known whether these instruments assess spasticity in accordance with the velocity-dependency defined by Lance. As other factors can modulate both the presence and the intensity of spasticity, standardization of the test protocol is required. This review focuses on the different instruments used to assess spasticity in children with spastic CP in the clinical setting, and their report on a standardized test protocol. Questions addressed in this review include: which instruments for the clinical assessment of spasticity are used in children with CP?; Is there standardization for the assessment at different velocities of passive joint movement and the testing posture of the patient?; How is spasticity quantified? . The search strategy included the terms 'spasticity', 'cerebral palsy', and 'child'. The references of retrieved articles were checked. All citations identified by this search were entered into a bibliographic management software programme, Reference Manager.
Method

SELECTION
The titles and abstracts were screened by one reviewer (VS). References were included if: (1) they included children (younger than 18 years) with a diagnosis of CP; (2) a clinical assessment of spasticity was described; (3) they were published as a full report or an abstract; and (4) the language was English, German, French, or Dutch.
DATA EXTRACTION
A data-extraction form was used to register: (1) patient characteristics; (2) the clinical spasticity instrument(s) used; (3) whether the test protocol reported on different velocities of testing and on the testing posture of the patient; and (4) the method of quantification. Some references did not describe the test protocol of the spasticity assessment, but reference 
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Results
INCLUDED STUDIES
The search strategy resulted in the retrieval of 937 citations from the electronic databases. Screening these citations on diagnosis and assessment of spasticity resulted in 193 studies, and reference tracking resulted in 18 additional studies. Thus, 211 references were identified, 119 of which fulfilled the inclusion criteria. The references that were included comprised 12 review or overview articles, 103 studies, and 4 case reports. In these 119 publications, 13 different clinical spasticity assessment instruments were used (Table II) , which form the basis for this review. Clinical grading scales for either spasticity or muscle tone have primarily been used to assess spasticity. Measurements of other excess symptoms that are related to spasticity (clonus and reflexes) were also reported in some of the references as being an 'assessment of spasticity'. Because these are not true spasticity measures, but other symptoms of impaired muscle activation (see Table I ) we did not include them in this review.
AVAILABLE ASSESSMENT INSTRUMENTS OF CLINICAL SPASTICITY
All of the instruments used for the clinical assessment of spasticity could be categorized into three main groups, according to their assessment technique and quantification (Table III) . The first group is referred to as the 'Ashworth-like scales', after Ashworth, 23 who first described the principle of muscle tone assessment by scoring the resistance encountered in a specific muscle group by passively moving a limb at one (non-) specified velocity through its ROM on a 5-point scoring scale. This is the original Ashworth scale (AS). 23 The AS has three modifications, all sharing the same principle. The first modification was made by the addition of an intermediate score, making it a 6-point scale: the Modified Ashworth scale-Bohannon (MAS-B). 24 A second modification combined the AS 23 with the MAS-B, 24 and added grading for the severity of spasticity: the Modified Ashworth scale-Peacock (MAS-P). 25 A third modification, the New York University Tone Scale (NYU), 26 combined the AS 23 with the ROM at a fast velocity stretch.
The second group is referred to as 'Tardieu-like scales', after Tardieu, 151 who described the principle of spasticity assessment by joint-angle measurement at different velocities of muscle stretch. Derived assessments are the Tardieu Scale (TS) 27 with which spasticity is clinically assessed by passive movement of the joints at three specified velocities and the intensity and duration of the muscle reaction to stretch (X) is rated on a 5-point scale, with the joint-angle (Y) at which this muscle reaction is first felt. This method is very time consuming. Therefore it was simplified to the Modified Tardieu Scale (MTS). 28 The MTS only defines the moment of the 'catch', seen in the ROM at a particular joint angle at a fast passive stretch.
The third group, 'Other Clinical Grading Scales', is a combination of clinical spasticity assessment scales or tests that can be distinguished from the other two groups, either because of their assessment technique or the method of quantification. A description of all scales is presented in Appendix 1.
Some references reported more than one clinical spasticity grading scale. As a consequence, spasticity was clinically assessed 135 times in the 119 included references. 'Ashworthlike scales' were used in 83% (112/135), 'Tardieu-like scales' in 10% (13/135), and 'Other Clinical Grading Scales' in 7% (10/135) of all reports of grading scales. The results will be reviewed for these three groups.
ASSESSMENT WITH DIFFERENT STANDARDIZED VELOCITIES
Of the 'Ashworth-like scales', only the original publication of NYU 26 described the assessment of each muscle performed by stretching the muscle at two velocities: 'slow' and 'fast', without further standardization. Of all references reporting on using the NYU, two references 134, 136 confirmed this multiple velocity stretching protocol, whereas two others 137, 138 simply referred to its original publication. 26 In the other 'Ashworth-like scales', as well as in the 'Other Clinical Grading Scales', the assessment involves stretching the muscle at only one (non-standardized) velocity.
Of the 'Tardieu-like scales', the original publication of the TS 27 stated that muscle stretch should be performed at three specified velocities: 'slow', 'under gravity', and 'fast' (without further standardization), referred to as V1, V2, and V3 respectively. Two references 139, 145 reporting on using the TS assessed the muscle stretch only at two velocities of stretch (V1 and V3). The MTS 28 was originally described as a muscle assessment at only a fast passive velocity stretch (V3). However, one reference 76 reporting on using the MTS described the assessment of muscle stretch at both slow and fast velocity (respectively V1 and V3). NYU, 26 and the Duncan Ely Test (DET) 31 defined a standardized posture of the patient while assessing muscle spasticity. They all emphasized the importance of a consistent position of the patient during assessment, as well as a consistent starting position of the tested limb with the TS and MTS. With the TS, MTS, and the NYU the patient should be assessed in a supine position with the head in midline, although the TS may also be performed sitting. For the DET, quadriceps should be assessed with the patient in a prone position. Three references 28,68,78 reporting on using the MTS confirmed supine testing or the use of a standardized testing protocol, whereas most others referred to the original MTS publication, 28 or to the original publication reporting on the TS, 27 in which a sitting testing posture is also described. One of the references 145 reporting on using the TS described assessment of the patient while supine lying; another only assessed the patient in a prone position (triceps surae testing). 139 Four references reporting on using the NYU 134,136-138 just referred to the original NYU publication. 26 All references 42, 143, 144 reporting on using the DET described a prone position.
A description of the standardized posture of a patient during testing was lacking in the original publications of the AS, 23 the MAS-B, 24 the MAS-P, 25 and other 'Other Clinical Grading Scales'. Only 12 of the references reporting on using Review 67 'Ashworth-like scales' and one of the references reporting on using 'Other Clinical Grading Scales' described a specified testing posture: 'lying supine' was the most common posture during both lower and upper extremity assessment for the other 'Ashworth-like scales'. 43, 69, 88, 89, 100, 124, 125, 129, 131 Three references 78, 80, 102 in which these scales were reported described a 'specified' protocol, but no further details.
QUANTIFICATION OF SPASTICITY
The common feature of all 'Ashworth-like scales' is grading the intensity of the muscle tone at one (non-) specified velocity. Even the NYU restricts its grading to a combined score for ROM and muscle tone intensity only at the fast velocity, despite assessment at both a slow and a fast velocity stretch (Appendix I). Over half of the references that reported on using an 'Ashworth-like scale' either gave a description of the scoring scale or referred to the original publication, or both. However, inconsistencies exist in the number of scoring options (e.g. MAS-P can be used either as a 5-point or a 6-point scale) as well as in the score ranges. Despite these different applications, the original scoring scales, as presented in Appendix I, are most frequently used. Both 'Tardieu-like scales' grade spasticity by measuring the joint angle at a fast velocity stretch (V3) at which an increase in muscle tone is encountered. The TS is more comprehensive, because it also measures the ROM at a slow velocity stretch, and the joint angle at which an increase in muscle tone is encountered at a moderate velocity stretch. The intensity of the muscle response is also scored on a 5-point scale at each of the three specified velocities. The joint angles measured during the slow and fast velocity stretches are referred to as 'R2' and 'R1' respectively (Appendix 1). Of all the references reporting on using the TS, one 139 involved the complete original scoring, and all the others 76, 89 only parts of it. One reference 76 reporting on using the MTS measured both the joint angles 'R1' and 'R2'. Two references 28,96 reporting on using the MTS suggested that the 'dynamic component' 6, 28 should be used as a clinical measure of spasticity, calculated as the difference between the joint angles R2 and R1. This can easily be calculated with the TS, but also with the MTS if passive ROM is tested.
Apart from the DET, 31 in which quadriceps spasticity is graded by shown buttock elevation, spasticity grading with the six different 'Other Clinical Rating Scales' varies from grading muscle tone, 145 or grading the joint angle in the ROM at which an increase in muscle tone is experienced, 32 to a more complex combination of these or other different parameters 30, 141, 146, 147 (Appendix 1). Because each of these 'Other Clinical Rating Scales' was used only once or twice, we did not extract these data.
Discussion
In 119 references, 13 different instruments were used for the clinical assessment of spasticity in children with CP. This review shows that most of these instruments do not comply with the concept of spasticity as defined by Lance: they mostly grade muscle tone intensity only at one (often non-specified) velocity of passive stretch. The references in which these instruments were used seldom standardized the testing posture of the patient. For the quantification of spasticity, most instruments grade the intensity of the muscle tone and ROM. However, the scoring systems of most instruments are ambiguous because different grading and score ranges have been used.
Comparison of research data on the treatment of spasticity is only possible if the exact scoring system has been defined.
Only the TS measures the velocity-dependent increase in muscle tone and compares the intensity and the angle of appearance of the increased muscle tone at three different movement velocities. Although the original publication of the NYU reports on the assessment of the muscle at slow and fast velocity stretches, the NYU grading does not comply with the concept of spasticity as its grading is restricted to the fast velocity stretch. The TS describes a very comprehensive method to assess patients, but it seems to be very time consuming. Its feasibility is, therefore, questioned, especially for use with children. This might explain the great variation in test protocols for the clinical application of this scale in the included references. Simplification of the test protocol is, therefore, desirable.
Although the TS takes the speed of the muscle stretch into account, no standardization of the three different velocities is described in the original publication. 27 Both the joint angle and the intensity of the muscle response are velocity dependent. Recently, Mackey et al. 148 measured the angular velocities with which the passive stretching of the elbow muscle is performed for assessment with the TS. The results showed great variances in the three angular velocities. To achieve a reliable assessment, it is, therefore, necessary to follow a standardized protocol.
With the TS the intensity of the muscle tone is scored on a 5-point scale (Appendix 1), in which clonus is set to be the highest level of spasticity. However, as shown in Table I , clonus is another excess symptom that is related to spasticity, 149 but not specific for the presence of spasticity. It also differs from spasticity in the muscles in which it can be evoked: clonus can only be evoked in specific muscles, whereas increased muscle tone can be evoked in all muscles.
The TS compares the angle of appearance of the increased muscle tone at three different movement velocities. A measure derived from the TS, used in the literature 96 as a clinical measure of spasticity, is the 'dynamic component'. 6 This can be calculated as the difference between the joint angle of the passive range of joint movement at a very slow passive stretch (R2) and the joint angle of the catch at a fast velocity stretch (R1). However, the calculated difference adds together the variances of both joint angles, resulting in very wide inter-sessional variations, as has been demonstrated in a recent study. 150 Therefore, to evaluate the treatment of spasticity, it is probably better to compare the maximal ROM at a very slow passive stretch before and after treatment and the joint angle of the catch at a fast velocity passive stretch before and after treatment.
Conclusion
According to the definition of spasticity, i.e. a velocity-dependent increase in muscle tone, the instruments that are most frequently used for the clinical assessment of spasticity in children with CP (the 'Ashworth-like scales') do not comply with the concept of spasticity. Only the original Tardieu Scale is a suitable instrument to measure spasticity. However, the original test protocol seems very time consuming, and lacks standardization of the muscle stretch velocities. Moreover, the rating of the intensity of the muscle response is not an exclusive measure of spasticity because it also includes clonus. Further research is needed to develop a clinical spasticity assessment instrument that complies with the concept of spasticity, with a detailed description of specific velocities of passive stretch, positioning of the patient, and grading of spasticity. Review 69
